Synthetic, or designer, drugs represent a serious public health risk. Compared to the traditional drugs for which they are sold as substitutes, synthetic drugs are often more potent and can result in life-threatening medical complications. One of the difficulties in preventing complications from synthetic drugs is that they go undetected by routine drug screens used in hospitals. Clinicians are therefore unaware of what the patient took. Moreover, determining when new synthetic drugs hit the street and whether there are complications related to their abuse is delayed. While samples can be sent to reference laboratories for testing, the results often do not come back for days or weeks making the tests of little help for the involved clinicians and are therefore rarely sent. Mass spectrometry is an attractive option for performing synthetic drug screens because it is sensitive, selective, and is a platform technology that can adapted relatively quickly as new agents emerge. The use of mass spectrometry for this purpose at or near the point of care is limited, however, due to the complexity of the analyses. The focus of this proposal is to simplify the entire analytical workflow required to perform mass spectrometric assays in order to make the use of MS assays more feasible for rapid screening of synthetic drugs. The core technology in the proposal is paper spray mass spectrometry, a direct analysis method in which biofluids samples such as blood can be analyzed directly without sample preparation. All of the components needed to perform the extraction and ionization of analytes from complex matrices can be contained within an inexpensive disposable cartridge. No sample preparation is performed, no solvent waste is generated, and no carry-over or clogging occur. These advantages make paper spray MS an attractive option for synthetic drug screening. The sensitivity of paper spray MS needs to be improved by about an order of magnitude to make it adequate for screening synthetic cannabinoids and fentanyl derivatives, however. In this proposal, we aim to develop and test a disposable paper spray cartridge that can dramatically improve the sensitivity of paper spray MS without increasing the complexity of the analysis. The general approach is to perform analyte preconcentration and separation from the sample matrix automatically on an inexpensive disposable cartridge, one requiring no special device or human action. We will also begin testing these methods on blood samples of patients presenting to the Emergency Department who are suspected to have used synthetic drug.

Public Health Relevance

A prerequisite to addressing the synthetic drug problem is a better understanding of what compounds are being used and the blood concentrations associated with acute intoxications. Currently this information is difficult to obtain because there are no effective methods to perform such measurements when patients present at emergency rooms during acute intoxications. This proposal focuses on developing a fast, sensitive, and relatively simply approach to measure blood samples in order to identify the both the chemical identity and the approximate concentration of synthetic drugs.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Exploratory/Developmental Grants (R21)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-IFCN-L (56))
Program Officer
Hillery, Paul
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
Schools of Arts and Sciences
United States
Zip Code